待处理
入排:排除
图源:待检查
Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Trial.
Zine-Eddine Khene, Delphine Borchiellini, Karim Bensalah
Eur Urol 83(5) 475-476
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板